Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy

Viruses trigger potent cytotoxic T cell responses, whereas anti-tumour immunity has been difficult to establish. Here the authors engineer a replicating viral delivery system for tumour-associated antigens, which induces alarmin release, innate activation and protective anti-tumour immunity in mice.

Guardado en:
Detalles Bibliográficos
Autores principales: Sandra M. Kallert, Stephanie Darbre, Weldy V. Bonilla, Mario Kreutzfeldt, Nicolas Page, Philipp Müller, Matthias Kreuzaler, Min Lu, Stéphanie Favre, Florian Kreppel, Max Löhning, Sanjiv A. Luther, Alfred Zippelius, Doron Merkler, Daniel D. Pinschewer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/a476030b446346deb07e1f28b441729c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a476030b446346deb07e1f28b441729c
record_format dspace
spelling oai:doaj.org-article:a476030b446346deb07e1f28b441729c2021-12-02T15:39:05ZReplicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy10.1038/ncomms153272041-1723https://doaj.org/article/a476030b446346deb07e1f28b441729c2017-05-01T00:00:00Zhttps://doi.org/10.1038/ncomms15327https://doaj.org/toc/2041-1723Viruses trigger potent cytotoxic T cell responses, whereas anti-tumour immunity has been difficult to establish. Here the authors engineer a replicating viral delivery system for tumour-associated antigens, which induces alarmin release, innate activation and protective anti-tumour immunity in mice.Sandra M. KallertStephanie DarbreWeldy V. BonillaMario KreutzfeldtNicolas PagePhilipp MüllerMatthias KreuzalerMin LuStéphanie FavreFlorian KreppelMax LöhningSanjiv A. LutherAlfred ZippeliusDoron MerklerDaniel D. PinschewerNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Sandra M. Kallert
Stephanie Darbre
Weldy V. Bonilla
Mario Kreutzfeldt
Nicolas Page
Philipp Müller
Matthias Kreuzaler
Min Lu
Stéphanie Favre
Florian Kreppel
Max Löhning
Sanjiv A. Luther
Alfred Zippelius
Doron Merkler
Daniel D. Pinschewer
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
description Viruses trigger potent cytotoxic T cell responses, whereas anti-tumour immunity has been difficult to establish. Here the authors engineer a replicating viral delivery system for tumour-associated antigens, which induces alarmin release, innate activation and protective anti-tumour immunity in mice.
format article
author Sandra M. Kallert
Stephanie Darbre
Weldy V. Bonilla
Mario Kreutzfeldt
Nicolas Page
Philipp Müller
Matthias Kreuzaler
Min Lu
Stéphanie Favre
Florian Kreppel
Max Löhning
Sanjiv A. Luther
Alfred Zippelius
Doron Merkler
Daniel D. Pinschewer
author_facet Sandra M. Kallert
Stephanie Darbre
Weldy V. Bonilla
Mario Kreutzfeldt
Nicolas Page
Philipp Müller
Matthias Kreuzaler
Min Lu
Stéphanie Favre
Florian Kreppel
Max Löhning
Sanjiv A. Luther
Alfred Zippelius
Doron Merkler
Daniel D. Pinschewer
author_sort Sandra M. Kallert
title Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
title_short Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
title_full Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
title_fullStr Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
title_full_unstemmed Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
title_sort replicating viral vector platform exploits alarmin signals for potent cd8+ t cell-mediated tumour immunotherapy
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a476030b446346deb07e1f28b441729c
work_keys_str_mv AT sandramkallert replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT stephaniedarbre replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT weldyvbonilla replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT mariokreutzfeldt replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT nicolaspage replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT philippmuller replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT matthiaskreuzaler replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT minlu replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT stephaniefavre replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT floriankreppel replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT maxlohning replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT sanjivaluther replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT alfredzippelius replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT doronmerkler replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
AT danieldpinschewer replicatingviralvectorplatformexploitsalarminsignalsforpotentcd8tcellmediatedtumourimmunotherapy
_version_ 1718386007417552896